![]() |
市場調查報告書
商品編碼
1316288
全球醫療器械 3D 列印市場 - 2023-2030 年Global Medical Device 3D Printing Market - 2023-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2022 年,全球醫療設備3D列印市場規模達到26 億美元,預計到2030 年將實現利潤豐厚的成長,達到79 億美元。在預測期內(2023-2030 年),全球醫療設備3D 列印市場預計將呈現15.7% 的年複合成長率。
3D 列印技術改變了假肢和矯形器的製造。這種技術可以製造出輕便、精確匹配的裝置,使用戶感覺更舒適、更有用。
外科醫生可以利用3D 列印技術製造出適合每位患者的手術指南和設備。這些手冊有助於提高手術效果,降低手術風險,並幫助進行精確的術前準備。此外,還可以製作特殊工具,以滿足特定的手術需求。
2023 年6 月,EOS、Precision ADM、Orthopaedic Innovation Centre (OIC) 和Tecomet 這四家醫療器械製造領域的公司建立了合作關係。此次合作將為醫療器械的積層製造提供全方位的解決方案。
要擴大積層製造醫療器械的規模,就必須全面了解整個流程鏈,其中不僅包括列印,還包括設計、後處理、測試、消毒和包裝等。通過與Tecomet、OIC 和Precision ADM 的合作,我們將在積層製造領域積累無與倫比的經驗,這將幫助醫療器械製造商克服監管環境中的困難,提供優質可靠的產品。
根據《3D 列印醫學》雜誌發表的文章,2022 年,美國食品和藥物管理局(FDA)將通過現有的醫療器械法規對3D 列印設備進行管制。然而,由於3D 列印技術正在醫療保健行業迅速普及,FDA 越來越有興趣制定專門針對照護端(PoC)3D 列印的標準和法規。
由於3D 列印醫療設備研究的最新發展,醫療點(PoC) 醫療設備的製造量迅速增加。儘管PoC 3D 列印有可能提高患者的治療效果並減少手術室的時間和費用,但這種設計和生產環境模糊了醫療設備製造商和治療提供商之間的區別,並引發了監管方面的不確定性。
COVID-19 大流行對醫療器械3D 列印市場產生了重大影響。由於COVID-19 檢測法規的訂定,檢測試劑盒和診斷工具的需求激增。鼻咽拭子和样本採集容器作為檢測試劑盒和診斷工具的一部分,採用3D 列印技術進行生產。利用3D 列印技術,可以快速製作出這些組件的原型並進行生產,從而幫助滿足日益成長的需求。
俄烏戰爭對醫療器械3D 列印市場的影響是複雜和多方面的。在衝突期間,政府和醫療系統可能會優先考慮應急準備、基礎設施和基本醫療需求。對醫療設備3D 列印等尖端技術的接受和投資可能會受到這種優先級和資源分配變化的影響。更緊急、更直接的需求可能會得到資金和關注。
The global medical device 3D printing market reached US$ 2.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 7.9 billion by 2030. The global medical device 3D printing market is expected to exhibit a CAGR of 15.7% during the forecast period (2023-2030).
The manufacturing of artificial limbs and orthotic devices has been transformed by 3D printing. The technique makes it possible to create lightweight, precisely fitting devices that are comfier and useful for the user.
Surgeons can use 3D printing to make surgical guidance and equipment that are unique to each patient. These manuals help to improve surgical outcomes, lower surgical risks, and aid in precise pre-operative preparation. Additionally, special tools might be created to meet certain surgical needs.
In June 2023, EOS, Precision ADM, Orthopaedic Innovation Centre (OIC), and Tecomet, four companies operating in the medical device manufacturing sector, established cooperation. An all-inclusive solution for the additive manufacture of medical devices will be offered by this cooperation.
Scaling up the manufacturing of AM medical devices necessitates a thorough understanding of the entire process chain, which goes beyond printing and includes, among other things, design, post-processing, testing, sterilization, and packaging. Incomparable experience in additive manufacturing will result from our collaboration with Tecomet, OIC, and Precision ADM, which will assist medical device manufacturers in navigating the difficulties of the regulatory environment and supplying high-quality, dependable goods.
As per the article published in 3D Printing in Medicine, in 2022, through already-existing medical device rules, the Food & Drug Administration (FDA) of the United States controls 3D-printed devices. However, because 3D printing is spreading quickly throughout the healthcare industry, the FDA is becoming more and more interested in creating standards and regulations specifically for point-of-care (PoC) 3D printing.
Manufacturing of point-of-care (PoC) medical devices has rapidly increased as a result of recent developments in 3D-printed medical device research. Despite the fact that PoC 3D printing has the potential to enhance patient outcomes and cut down on operating room time and expenses, such a design and production environment blurs the distinction between medical device manufacturers and providers of treatment and raises regulatory uncertainty.
The COVID-19 pandemic has had a significant impact on the medical device 3D printing market. The demand for testing kits and diagnostic tools surged as a result of the COVID-19 testing regulations. Nasopharyngeal swabs and sample-collecting containers were produced using 3D printing as part of testing kits and diagnostic tools. Utilizing 3D printing, it was possible to quickly prototype and produce these components, helping to satisfy the growing demand.
The impact of the Russia-Ukraine war on the medical device 3D printing market is complex and multifaceted. Governments and healthcare systems may prioritize emergency preparedness, infrastructure, and essential healthcare requirements during times of conflict. The acceptance and investment in cutting-edge technologies like 3D printing for medical devices could be impacted by this change in priorities and resource allocation. More urgent and immediate demands may receive funding and attention.
The global medical device 3D printing market is segmented based on product, technology, application, end-user, and region.
The electron beam melting segment accounted for the highest market stake accounting for approximately 36.1% of the medical device 3D printing market in 2022. In the 3D manufacturing technique known as electron beam melting (EBM), a high-energy electron beam melts a metal powder. An object that precisely matches the criteria specified by a CAD model is created by melting multiple layers of powdered metal under the control of an electron beam, which generates an electron stream that is guided by a magnetic field.
In order to protect highly reactive materials from oxidation, production is done in a vacuum chamber. Similar to Selective Laser Melting (SLM), Electron Beam Melting (EBM) prints from a powder from the powder bed of the 3D printer, but EBM utilizes an electron beam as opposed to a laser.
North America is expected to dominate the Medical Device 3D Printing market, accounting for around 38.7% of this market. In March 2023, with a collaboration with 3D Systems, the manufacturer of medical devices Paragon Medical is investing in additive manufacturing capabilities. According to reports, the new cooperation will make use of the historical knowledge and competencies that both institutions can offer to clients.
The collaboration between the companies covers material procurement and supply, part design and process development, machine onboarding and validation, and regulatory assistance. The partnership between 3D Systems and Paragon Medical will enable them to grow the production of medical devices using cutting-edge metal and plastic 3D printing technology.
The major global players in the market include: Stratasys Ltd., EnvisionTEC, Koninklijke Philips N.V., 3D Systems, Inc., EOS, Renishaw plc, Materialise, 3T Additive Manufacturing Ltd., General Electric Company, Carbon, Inc., and Prodways Group among others.
The global medical device 3D printing market report would provide approximately 69 tables, 72 figures, and 195 Pages.
LIST NOT EXHAUSTIVE